Chapter 155: Barrier and New Mission
"Mr. Reyes…what's the situation?" Juliet arrived promptly from the emergency call from Michael.
"Juliet…read this article," Michael said, handing her his tablet.
Juliet took the tablet and scanned the article, her eyes narrowing as she digested the information. "This new regulation from China... it's directly targeting foreign solar companies, isn't it?"
"Yes, it seems they're putting barriers specifically to keep us out," Michael replied, his voice laced with frustration. "I suspect JinkoSolar is behind this. They're pushing to eliminate competition in their home market."
"We need to act fast," Juliet suggested. "We should consult our legal team to challenge these regulations. There might be a way to contest this through international trade laws."
"But that is too much of a hassle," Michael said and then remembered something. "Wait…isn't our target China? China has a larger market for solar panels than America, and we need to penetrate their market to achieve our global expansion goals. What if we use international law to our advantage? Can we challenge these regulations in the World Trade Organization?"
Juliet nodded thoughtfully. "That's a valid point, Mr. Reyes. The WTO has mechanisms for resolving trade disputes. If these regulations violate international trade agreements, we could file a complaint. It would put pressure on China to justify their actions under global trade norms."
Michael leaned back in his chair, contemplating the strategy. "That could also bring international attention to the issue. If we frame it as a fight for fair trade and innovation, it could garner support from other markets and stakeholders. So, Juliet, you know what to do with these."
"I'll have it researched right away."
With that, Juliet exited Michael's office and headed to her office. She quickly opened her monitor and then started researching how to file a protest to the WTO against China's recent trade policy.
She found that the process involved several steps, starting with a consultation phase where the complaining party formally requests consultations with the other party to try to resolve the dispute amicably.
Juliet took meticulous notes on the requirements: the complaint must be written and provide specific details of the measures in question and the legal basis for the complaint, referencing specific agreements and commitments under the WTO framework.
She then learned that if consultations failed to resolve the dispute within 60 days, the complainant could request the establishment of a panel. This panel, composed of three or more experts in trade law and policy, would examine the case, consider the arguments of both sides and issue a report detailing its findings and recommendations.
Juliet's screen was filled with tabs on WTO procedures, legal precedents, and case studies of similar disputes. She started drafting a document outlining the initial steps SolaraTech needed to take, including gathering comprehensive data on how China's new regulations affected their business and potentially violated specific commitments under the WTO's legal framework.
Three hours later, she compiled a preliminary action plan. This document outlined the stages of the complaint process, necessary documentation, and the timeline for each phase.
It also included potential arguments they could use to demonstrate how China's regulations were disproportionately affecting SolaraTech and possibly violating the General Agreement on Tariffs and Trade (GATT) principles, particularly those related to nondiscrimination and market access.
Juliet knew the importance of building a strong case supported by data and precedent. She planned to gather evidence of how the new regulations specifically targeted foreign companies like SolaraTech, impacting their market access and creating an unfair competitive advantage for Chinese companies.
Her next step was to coordinate with SolaraTech's legal department to refine the draft, ensuring every argument was legally sound and backed by substantial evidence. She also noted the need to consult with international trade law experts who could provide insight into the likelihood of success and potential challenges they might face during the dispute process.
***
Meanwhile, while Juleit was busying herself with her work, Michael on the other hand received a new notification from the system.
[New Mission Unlocked: Establish New Enterprise: Depending on your main enterprise, the photovoltaic company, wouldn't lead you to build a business empire if the product you are selling is being blocked by the world's largest market share in solar panels. Your mission is to start another company that is as lucrative as your solar panels.]
[Suggestion: You could start with the one in your mind, a pharmaceutical company. Compared to the photovoltaic company, which is a luxury for the masses to afford, a pharmaceutical company is a necessity. Medicines are essential, and the demand is always there, irrespective of economic conditions.
This could be your way to diversify and strengthen your business portfolio, ensuring stability and consistent growth.
Plus, with the ongoing global health challenges, there's a clear and immediate need for innovative pharmaceutical solutions. You can leverage the research and development capabilities of your solar panel enterprise to innovate in the pharmaceutical sector, perhaps focusing on sustainable and environmentally friendly production methods.
This new venture could also open doors to markets that are less susceptible to the kind of political and trade pressures you're facing with the solar panel business.]
[Rewards: 200,000 System Points]
Michael read that long text and nodded in understanding. The system was right, he couldn't just have it all depend on photovoltaic energy alone. The pharmaceutical industry presented a new arena with its challenges and opportunities. He had to think about the long-term viability of his business empire.
"Pharmaceuticals, huh?" he murmured to himself, considering the shift. "I have planned it long ago to bring down the company my father has built. He left us and I will make sure to destroy his legacy."
The one he had in mind was a company that would do the impossible, a cure for cancer. Now there is no cure for cancer as of yet. The reason for this is that there are too many variants of the disease, and it adapts quickly to new treatments. Fortunately, he has the technological system in his possession.
That is settled, Michael is going to establish a new enterprise, a pharmaceutical company. It's going to be exhilarating, he already wondered what the reaction of the public and pharmaceutical giants would be if such a cure is found.